Serial Number | 79391456 |
Word Mark | MATRICELF |
Filing Date | Monday, November 27, 2023 |
Status | 645 - FINAL REFUSAL - MAILED |
Status Date | Tuesday, January 7, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Biological implants, namely, implants comprising living tissue; biological tissue for implantation, namely, biological tissue grafts, implants comprising living tissue; biological tissue cultures for medical purposes; engineered biological tissues for medical purposes, namely, engineered biological tissue cultures for medical purposes; engineered human biological tissues for use in regenerative medicine, namely, engineered biological tissue cultures for medical purposes for use in regenerative medicine; engineered biological tissues for the treatment of spinal cord injuries, namely, engineered biological tissue cultures for medical purposes for the treatment of spinal cord injuries; biological implants for spinal cord injuries, namely, implants comprising living tissue; bio-printed personalized medical implants comprised of living tissue; a personalized bio-printed medical tissue implant adapted to fill a surgically defined cavity, namely, personalized bio-printed implants comprising living tissue; Transplants, namely, implants comprising living tissue; surgical implants comprising engineered living tissue; surgical implants comprising living tissue grown from stem cells; engineered human hydrogel and differentiated stem cells in the nature of biological tissues in the nature of biological tissue cultures for medical purposes; engineered human hydrogel for medical purposes; stem cells for medical purposes; biomaterials in the nature of biological tissue cells for printing engineered tissues for medical purposes |
Goods and Services | Regenerative medicine services; medical services, namely, tissue regeneration services; medical services, namely, tissue regeneration services using tissue engineering technology; medical services, namely, cellular therapy services; medical services, namely, regenerating and restoration of spinal cord tissue by means of implanting engineered tissues in the spinal cord; biomedical services, namely, treating human tissues for medical purposes; medical services relating to the removal, treatment and processing of human tissues; medical services relating to the removal, treatment and processing of human tissues for implantation |
Goods and Services | Scientific services relating to processing human tissues and cells, namely, stem cell production and tissue engineering services for processing human tissues and cells; medical and scientific research and development of human tissues and stem cells; medical and scientific research and development in the field of personalized medicine 3D bioprinting; stem cell research services; scientific and technological services in the field of regenerative medicine, namely, medical research, scientific research and development; medical and scientific research and development in the field of regenerative medicine; medical and scientific research and development in the field of spinal cord injuries; pharmaceutical and biological research and development services in the field of tissue regeneration and engineering |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 14, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 14, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 14, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Matricelf Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 22 - NOT AVAILABLE |
Address | IL |
Event Date | Event Description |
Thursday, March 14, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Wednesday, March 20, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, April 24, 2024 | APPLICATION FILING RECEIPT MAILED |
Saturday, June 29, 2024 | NON-FINAL ACTION WRITTEN |
Sunday, June 30, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, July 25, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Thursday, July 25, 2024 | REFUSAL PROCESSED BY MPU |
Sunday, August 11, 2024 | REFUSAL PROCESSED BY IB |
Wednesday, December 25, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, December 25, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, December 25, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Wednesday, December 25, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, December 25, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, December 25, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, December 25, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, January 7, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Tuesday, January 7, 2025 | FINAL REFUSAL E-MAILED |
Tuesday, January 7, 2025 | FINAL REFUSAL WRITTEN |
Wednesday, June 26, 2024 | ASSIGNED TO EXAMINER |
Thursday, December 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |